Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
Natalizumab and monocytes in multiple sclerosis: The dim haze of mystery and the enchantment of pursuit.
The prevalence of urinary catheterization in women and men with multiple sclerosis.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
Multiple sclerosis and the blood-central nervous system barrier.
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Disability in multiple sclerosis: When synaptic long-term potentiation fails.
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
Multiple sclerosis: a review of the disease and treatment options.
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis.
Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging.
Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.
Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.
Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.
Transient Brain Lesions in Neuro-Behçet's Disease without Systemic Involvement.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Vitamin d and long-term memory in multiple sclerosis.
Pages
« first
‹ previous
…
400
401
402
403
404
405
406
407
408
…
next ›
last »